Open an account

OraSure Technologies

OSUR · NASDAQ

$3.75+$0.065 (+1.77%)TodayMarket closed ·
Prev close $3.68

About OSUR

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. The company is headquartered in Bethlehem, Pennsylvania and currently employs 500 full-time employees. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its products and services include OraQuick ADVANCE Rapid HIV 1/2 Antibody Test, OraQuick HIV Self-Test, Diagnostics Direct Syphilis Health Check, OraQuick Ebola Rapid Antigen Test, InteliSwab COVID-19 Rapid Test Pro, and SickleSCAN Test, among others. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers.

Employees
500
Headquarters
Bethlehem, Pennsylvania
Listed
Nov 17, 1986
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
orasure.com

OSUR key statistics

Market cap
258.29M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
525.47K
Volume
406.44K
Open price
$3.70
High today
$3.79
Low today
$3.68
52 Week high
$4.58
52 Week low
$2.08

OraSure Technologies (OSUR) at a glance

OraSure Technologies (OSUR) last traded at $3.75, with a market cap of 258.29M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $3.68 and $3.79. The current price is 1.9% above the day's low and 1.1% below its high.

Volume so far is 406.44K shares, below the average of 525.47K shares a day.

Over the past year OraSure Technologies has ranged from $2.08 to $4.58, and now sits 67% of the way up that range.

OraSure Technologies met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q2 FY26 it reported $0.09 per share against an estimate of -$0.2754.

The average analyst price target is $4.08, 8.9% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 1 analyst rating say Buy
  • Buy0.0%
  • Hold100.0%
  • Sell0.0%
Price target · 3 analystsAvg $4.08
Low
$4.04
Now
$3.75
High
$4.20

OSUR earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 52.6% on average.

  1. Q3 FY24: reported -$0.06 per share against an estimate of -$0.0782
  2. Q4 FY24: reported -$0.14 per share against an estimate of -$0.0578
  3. Q1 FY25: reported -$0.21 per share against an estimate of -$0.2091
  4. Q2 FY25: reported -$0.26 per share against an estimate of -$0.2091
  5. Q3 FY25: reported -$0.19 per share against an estimate of -$0.1938
  6. Q4 FY25: reported -$0.27 per share against an estimate of -$0.2091
  7. Q1 FY26: reported -$0.32 per share against an estimate of -$0.1892
  8. Q2 FY26: reported $0.09 per share against an estimate of -$0.2754

OSUR news

  • World Health Organization Director General Determined That The Ebola Epidemic In DRC Still Meets Criteria Of Public Health Emergency Of International Concern, But Not Those Of A Pandemic Emergency

  • 12 Health Care Stocks Moving In Friday's After-Market Session

  • Press releaseBusiness Wire

    Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance

  • Press releaseBusiness Wire

    Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors

  • Press releaseBusiness Wire

    Altai Capital Management Announces Intention to Nominate Two Highly-Qualified Candidates for Election to OraSure Board of Directors

  • Earnings Scheduled For August 5, 2025

Similar companies

Companies in the same industry as OraSure Technologies

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.